Dr. Shaolong Qi, Jilin University, China
Dr. Shaolong Qi 🧪, an Associate Professor at China-Japan Union Hospital of Jilin University 🏥, is a distinguished researcher specializing in lymphatic imaging 🧬 and supramolecular theranostics 💡. Born in Shandong, China 🇨🇳, he earned his Ph.D. 🎓 in 2020 from Jilin University under Prof. Jianshi Du. After a postdoctoral fellowship 🧑🔬 at Tsinghua University with Prof. Guocan Yu, he began his independent research career in 2024. With over 40 publications 📝 in renowned journals like Adv. Mater. and ACS Nano, his work integrates cutting-edge nanomedicine and cancer immunotherapy. Dr. Qi is also a dedicated member of Jilin’s surgical professional committee.
Professional Profile:
Google Scholar
Suitability of Dr. Shaolong Qi for the Best Researcher Award
Dr. Shaolong Qi is a trailblazer in lymphatic imaging and supramolecular theranostics, merging nanotechnology and medicine to address critical challenges in healthcare. With a robust academic foundation, impactful research contributions, and over 40 publications in top-tier journals, Dr. Qi has established himself as a leader in the fields of cancer immunotherapy, advanced imaging, and therapeutic nanomedicine. His dedication to advancing translational medicine and mentoring aspiring scientists underscores his holistic approach to impactful research and scientific leadership, making him an exemplary candidate for the Best Researcher Award.
Education and Experience
- 🎓 B.S. in Clinical Medicine: Shandong Second Medical University, 2009–2014
- 🎓 M.S.: China-Japan Union Hospital of Jilin University, 2014–2017 (Advisor: Prof. Chong Ma)
- 🎓 Ph.D.: Jilin University, 2017–2020 (Advisor: Prof. Jianshi Du)
- 🧪 Postdoctoral Fellow: Department of Chemistry, Tsinghua University, 2021–2024 (Advisor: Prof. Guocan Yu)
- 🏥 Associate Professor: China-Japan Union Hospital of Jilin University, 2024–Present
Professional Development
Dr. Shaolong Qi’s career trajectory reflects a commitment to advancing healthcare through nanotechnology and imaging 🩺. His expertise spans lymphatic imaging 🌟, supramolecular nanomedicine 🧬, and cancer immunotherapy 💉. As a postdoctoral researcher at Tsinghua University, he contributed to pioneering mRNA vaccine delivery and phototheranostics 🔬. His publications, exceeding 40 in number 📚, are widely cited, showcasing his impact on the scientific community. Currently, as an Associate Professor, Dr. Qi mentors aspiring researchers 🧑🏫 and drives innovation in theranostics and advanced imaging technologies, further cementing his role as a leader in integrative nanomedicine development 🚀.
Research Focus
Dr. Shaolong Qi’s research focuses on the intersection of nanotechnology and medicine 🧪. His primary areas of interest include lymphatic imaging 🩺, leveraging advanced near-infrared fluorescence for precise diagnostic applications 🔬. He also specializes in supramolecular theranostics 🧬, utilizing host–guest chemistry for targeted drug delivery and cancer immunotherapy 💉. His work on cancer vaccines 🌟 integrates cutting-edge nanoparticle design for enhanced antigen delivery and immune modulation 🌐. With an emphasis on translational medicine, Dr. Qi’s contributions aim to bridge innovative scientific approaches with real-world healthcare solutions 🚑, improving diagnostics and therapeutic outcomes for complex diseases.
Awards and Honors
- 🏆 2024: Outstanding Postdoctoral Innovation Award, Department of Chemistry, Tsinghua University
- 🏅 2023: Outstanding Postdoctoral Excellence Award, Tsinghua University
- 🏆 2022: Outstanding Postdoctoral Innovation Award, Tsinghua University
- 🎖 2019: Postgraduate Academic Performance Scholarship, Jilin University
- 🥇 2016: National Scholarship for Graduate Students, Ministry of Education, China
Publication Top Notes:
-
📖 Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies — 🧬 Theranostics, 2022, Cited by: 107
-
💊 A hybrid supramolecular polymeric nanomedicine for cascade‐amplified synergetic cancer therapy — 🔬 Angewandte Chemie, 2022, Cited by: 63
-
⚡ Shear stress and ROS-responsive biomimetic micelles for atherosclerosis via ROS consumption — 🧪 Materials Science and Engineering: C, 2021, Cited by: 37
-
🧬 Suprasomes based on host–guest molecular recognition: an excellent alternative to liposomes in cancer theranostics — 🔬 Angewandte Chemie, 2022, Cited by: 35
-
🛡️ Supramolecular engineering of cell membrane vesicles for cancer immunotherapy — 🧫 Science Bulletin, 2022, Cited by: 32